Location: Home
  • search
  • go
  • Relate News
  • 9/8/2020CANbridge Enters 2nd Rare Disease Gene Therapy Deal with UMass Med Sch...
  • 9/7/2020Ascentage's Bcl-2 Inhibitor APG-2575 Granted Orphan Drug Status by USF...
  • 9/7/2020CPA Releases the List of Excessively-Supplied Drug Products (6th Batch...
  • 9/7/2020NMPA Publicizes the List of Reference Formulations for GQCE Studies (3...
  • 9/7/2020Listed Chinese MedPharm Cos Saw Flat Revenue Growth But Higher Net Pro...
  • 9/7/2020Fosun and Sinopharm Enter Deal to Supply BioNTech Coronavirus Vaccine ...
  • 9/6/2020NMPA Publicizes the List of Reference Formulations for GQCE Studies (3...
  • 9/4/2020Recent Executive Moves
  • 9/4/2020NHC Announces Its Legislation Plan of Departmental Regulations in 2020
  • 9/4/2020NMPA Issues List of Reference Formulations for Generic Drug Equivalenc...
  • 9/4/2020AbbVie Teams Up with I-Mab in Cancer
  • 9/4/2020Uni-Bio Receives IND Approval for Uni-PTH Liquid Injection in China
  • 9/4/2020CStone Gets Ready to Launch Lung Cancer Drug Sugemalimab in China Befo...
  • 9/3/2020Innovent Granted Marketing Approval for SULINNO (Adalimumab Inj) in Ch...
  • 9/3/2020Alphamab's KN046 Granted Orphan Drug Designation for TET by USFDA
  • 9/3/2020Asymchem Invests in Flow Chemistry Startup Snapdragon
  • 9/3/2020China Tightens Technology Export Control Rules
  • 9/3/2020Chi-Med Initiates PII Trial of HMPL-453 for IHCC in China
  • 9/3/2020Lancet: Chinese Population to Half by 2100 with Sharp Labor Force Decl...
  • 9/3/2020Carlyle Buys Minority Stake in Shenzhen Salubris Pharma
  • 9/2/2020NHC Publishes the List of 2nd Rare Disease Treatment and Insurance Exp...
  • 9/2/2020NMPA Issues the Dispute Resolution Procedures for Drug Evaluation Deci...
  • 9/2/2020CDE Solicits Comments on the Draft Guidelines for Clinical Pharmacolog...
  • 9/2/2020As MNCs Refocus on Innovative Drugs, Feel the Pulse of China's IP Land...
  • 9/1/2020China's Pre-Revenue Biopharma Players Continue To Be Embraced By Marke...
  • 9/1/2020HJB and Ansun Enter Strategic Deal on Biologics CMC Partnership
  • 9/1/2020Antengene Cleared to Stage $200 Million IPO in Hong Kong
  • 9/1/2020Polyphor and Fosun Pharma Announce Licensing Deal for Balixafortide in...
  • 9/1/2020CStone Receives USFDA IND Clearance for Anti-PD-L1 Sugemalimab in R/R ...
  • 8/31/2020Financial-related Company News in Brief
  • Page:222/775 Total number of articles:23222: [First][<<] [220] [221] [222] [223] [224] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group